Andrew J B Watts
Overview
Explore the profile of Andrew J B Watts including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
158
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bressendorff I, Nelveg-Kristensen K, Ghasemi M, Watts A, Elversang J, Keller K, et al.
Kidney Int Rep
. 2024 Sep;
9(9):2829-2831.
PMID: 39291184
No abstract available.
2.
Fujita Y, Watts A, Ichikawa D, Shibagaki Y, Suzuki T, Keller K, et al.
Kidney Int Rep
. 2024 Aug;
9(8):2563-2566.
PMID: 39156160
No abstract available.
3.
Batal I, Watts A, Gibier J, Hamroun A, Top I, Provot F, et al.
Kidney Int
. 2024 Aug;
106(4):749-752.
PMID: 39127225
No abstract available.
4.
Horinouchi T, Nagano C, Watts A
Pediatr Nephrol
. 2023 Jul;
39(1):337.
PMID: 37495741
No abstract available.
5.
Watts A, Weins A
J Am Soc Nephrol
. 2022 Sep;
33(11):1959-1960.
PMID: 36137754
No abstract available.
6.
Watts A, Keller K, Weins A
J Am Soc Nephrol
. 2022 Jan;
33(3):654.
PMID: 35064049
No abstract available.
7.
Watts A, Keller K, Lerner G, Rosales I, Collins A, Sekulic M, et al.
J Am Soc Nephrol
. 2021 Nov;
33(1):238-252.
PMID: 34732507
Background: Failure of the glomerular filtration barrier, primarily by loss of slit diaphragm architecture, underlies nephrotic syndrome in minimal change disease. The etiology remains unknown. The efficacy of B cell-targeted...
8.
Kost-Alimova M, Sidhom E, Satyam A, Chamberlain B, Dvela-Levitt M, Melanson M, et al.
Cell Rep Med
. 2020 Dec;
1(8):100137.
PMID: 33294858
Drug repurposing has the advantage of identifying potential treatments on a shortened timescale. In response to the pandemic spread of SARS-CoV-2, we took advantage of a high-content screen of 3,713...
9.
Denton A, Carr E, Magiera L, Watts A, Fearon D
J Exp Med
. 2019 Jul;
216(10):2242-2252.
PMID: 31324739
The induction of adaptive immunity is dependent on the structural organization of LNs, which is in turn governed by the stromal cells that underpin LN architecture. Using a novel fate-mapping...
10.
Shah A, Watts A, Mehta A, Wechalekar A
Int J Hematol
. 2009 Dec;
91(1):121-3.
PMID: 20020230
We report an unusual dermatological reaction to bortezomib in a 61-year-old man with AL amyloidosis. Systemic AL amyloidosis is a rare complication of monoclonal gammopathy or myeloma in which abnormally...